SGLT2 inhibitors have transformed care for people with type 2 diabetes. They not only lower blood…
Blog
CAGE Bio Announces Start of Double-Blind Vehicle-Controlled Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment
SAN CARLOS, Calif. and DALLAS, Oct. 23, 2025 /PRNewswire/ — CAGE Bio Inc., a clinical-stage biotechnology…
Why burnout prevention starts with leadership
Many people have become “burned out” on the word burnout. Many doctors do not resonate with…
Dr. Steven J. Corwin to Step Down as NewYork-Presbyterian President and CEO in January; NewYork-Presbyterian Executive Vice President and COO Dr. Brian G. Donley Named His Successor
“It’s an honor and privilege to have the opportunity to lead this extraordinary institution, which is…
Why the MAHA plan is the wrong cure
“Make America Healthy Again (MAHA).” Finally, something we can all agree on. The new MAHA report…
American Joint Replacement Registry Marks Record Growth, Strengthens Global Collaboration
The newly released 12th Annual Report highlights new data methodology and stronger collaborations shaping the future…
What AI can never replace in medicine
When I opened my dermatology practice 25 years ago, I used paper charts, a prescription pad,…
Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight
The mismatch repair deficiency market is experiencing significant growth, driven by increasing awareness and adoption of…
Pancreatic cancer racial disparities
The names read like a roll call of Black excellence: congressman John Lewis, the civil rights…
Why faith and academia must work together
Ten years. That’s how long I carried around this idea I just couldn’t seem to put…